EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia
https://www.zacks.com/stock/news/2250019/ema-accepts-rocket-rckt-gene-therapy-filing-for-fanconi-anemia?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250019
Apr 03, 2024 - The EMA accepts Rocket's (RCKT) regulatory submission seeking approval for RP-L102, a gene therapy for a rare genetic disorder called fanconi anemia that affects the bone marrow.
0
Pages: 1
Page 1